Your browser doesn't support javascript.
loading
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
Mentzer, Alexander J; O'Connor, Daniel; Bibi, Sagida; Chelysheva, Irina; Clutterbuck, Elizabeth A; Demissie, Tesfaye; Dinesh, Tanya; Edwards, Nick J; Felle, Sally; Feng, Shuo; Flaxman, Amy L; Karp-Tatham, Eleanor; Li, Grace; Liu, Xinxue; Marchevsky, Natalie; Godfrey, Leila; Makinson, Rebecca; Bull, Maireid B; Fowler, Jamie; Alamad, Bana; Malinauskas, Tomas; Chong, Amanda Y; Sanders, Katherine; Shaw, Robert H; Voysey, Merryn; Snape, Matthew D; Pollard, Andrew J; Lambe, Teresa; Knight, Julian C.
  • Mentzer AJ; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK. alexander.mentzer@ndm.ox.ac.uk.
  • O'Connor D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Bibi S; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Chelysheva I; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Clutterbuck EA; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Demissie T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Dinesh T; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Edwards NJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Felle S; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Flaxman AL; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Karp-Tatham E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Li G; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Liu X; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Marchevsky N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Godfrey L; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Makinson R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Bull MB; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Fowler J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Alamad B; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Malinauskas T; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Chong AY; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Sanders K; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Shaw RH; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Voysey M; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Snape MD; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
  • Lambe T; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Knight JC; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nat Med ; 29(1): 147-157, 2023 01.
Article en En | MEDLINE | ID: mdl-36228659
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase II / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / COVID-19 / Infección Irruptiva Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase II / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / COVID-19 / Infección Irruptiva Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article